Inclusion and exclusion criteria
We selected all PRIDE Study participants with an estimated date of
delivery in 2012-2019 (N = 9,054) and participants in The Dutch
Pregnancy Drug Register with an estimated date of delivery in 2014-2019
(N = 3,911). Participants included in both cohorts were included only
once, retaining the record with most complete information. Participants
who were diagnosed with early-onset preeclampsia (pathophysiology
differs from late-onset preeclampsia)18 or who
delivered before gestational week 34 (not at risk for the outcome of
interest) were excluded.